Global Assets Advisory’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $331K | Sell |
2,593
-4,722
| -65% | -$603K | 0.13% | 150 |
|
|
2025
Q1 | $866K | Buy |
7,315
+5,258
| +256% | +$622K | 0.16% | 122 |
|
|
2024
Q4 | $273K | Buy |
+2,057
| New | +$273K | 0.15% | 126 |
|
|
2024
Q2 | – | Sell |
-481,413
| Closed | -$3.52M | – | 265 |
|
|
2024
Q1 | $3.52M | Buy |
+481,413
| New | +$3.52M | 0.16% | 113 |
|
|
2023
Q4 | – | Sell |
-8,502
| Closed | -$1.04M | – | 85 |
|
|
2023
Q3 | $1.04M | Sell |
8,502
-60
| -0.7% | -$7.34K | 0.92% | 28 |
|
|
2023
Q2 | $1.09M | Buy |
8,562
+137
| +2% | +$17.4K | 0.99% | 30 |
|
|
2023
Q1 | $1.12M | Sell |
8,425
-111
| -1% | -$14.7K | 1.14% | 21 |
|
|
2022
Q4 | $1.12M | Sell |
8,536
-1,455
| -15% | -$191K | 1.18% | 19 |
|
|
2022
Q3 | $1.29M | Buy |
+9,991
| New | +$1.29M | 1.3% | 17 |
|